Positive (sera from infected dogs) and negative (sera from negative dogs) controls provided by the manufacturer were included in each test and assayed at the same dilutions of the sera samples.
Mice were assayed at multiple time points by the following tests in the specified sequence so as not to interfere with the other tests: (1) open field assay, (2) light/dark assay, (3) nesting, (4) parallel rod footslip, and (5) contextual and cued conditioned fear, as previously described (Chao et al., 2010).
Cross-laboratory comparison of the OncoScan® (Affymetrix Inc) assay's performance was evaluated by running the assay at the three test laboratories on plates containing the same set of samples and by following the recommended protocol outlined in the OncoScan® assay manual.
Specimens were tested using the same HPV assay at the same testing laboratory ensuring consistency of results.
Specimens were assayed only at the site that performed original testing.
Cell count and viability were assessed by trypan blue exclusion dye assay at the conclusion of tests, using control cultures; cell typing of residual cells was also performed by flow cytometry (murine mAb anti-human CD14 by Coulter Electronics Inc., Miami Lakes, FL, USA and Epics Elite cytometer by Coulter Electronics) at the conclusion of tests, using control cultures.
Its weak estrogenicity was seen only in the MCF-7 focus assay at the highest concentration tested--10 microM.
Among both extracts, butanol extract shows maximum inhibition of 93.88%, 80.02%, 52.06%, 94.68%, and 69.37% in DPPH, non-site-specific and site-specific, FTC, and TBA assays and absorbance of 0.852 and 0.522 in reducing power and CUPRAC assay at the highest concentration tested.
Several factors were associated with testing false-recent on the assays among HIV-positive participants with known LTI, including having been classified as RI by the assays at baseline; more frequent history of HIV testing; and older age (borderline significant association).
Hemolysis assay suggests almost no hemolysis at the tested concentrations (up to 1 mg/mL) for MNPs compared to the sodium dodecyl sulfate (positive control).
